Free Trial

Hyperfine (HYPR) Stock Price, News & Analysis

Hyperfine logo
$0.80 +0.03 (+4.03%)
As of 11:59 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Hyperfine Stock (NASDAQ:HYPR)

Key Stats

Today's Range
$0.79
$0.83
50-Day Range
$0.54
$0.86
52-Week Range
$0.53
$1.90
Volume
110,498 shs
Average Volume
899,099 shs
Market Capitalization
$62.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.06
Consensus Rating
Moderate Buy

Company Overview

Hyperfine Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

HYPR MarketRank™: 

Hyperfine scored higher than 64% of companies evaluated by MarketBeat, and ranked 379th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Hyperfine has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Hyperfine has only been the subject of 2 research reports in the past 90 days.

  • Read more about Hyperfine's stock forecast and price target.
  • Earnings Growth

    Earnings for Hyperfine are expected to grow in the coming year, from ($0.57) to ($0.53) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Hyperfine is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Hyperfine is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Hyperfine has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Hyperfine's valuation and earnings.
  • Percentage of Shares Shorted

    5.17% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hyperfine has recently decreased by 7.74%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Hyperfine does not currently pay a dividend.

  • Dividend Growth

    Hyperfine does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.17% of the float of Hyperfine has been sold short.
  • Short Interest Ratio / Days to Cover

    Hyperfine has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Hyperfine has recently decreased by 7.74%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Hyperfine has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Hyperfine this week, compared to 1 article on an average week.
  • Search Interest

    Only 6 people have searched for HYPR on MarketBeat in the last 30 days. This is a decrease of -14% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Hyperfine insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,610.00 in company stock.

  • Percentage Held by Insiders

    30.98% of the stock of Hyperfine is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.03% of the stock of Hyperfine is held by institutions.

  • Read more about Hyperfine's insider trading history.
Receive HYPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyperfine and its competitors with MarketBeat's FREE daily newsletter.

HYPR Stock News Headlines

Hyperfine, Inc. (HYPR) - Yahoo Finance
Hyperfine Short Interest Report
The DOJ Just Paved the Way for Account Seizures
Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.
See More Headlines

HYPR Stock Analysis - Frequently Asked Questions

Hyperfine's stock was trading at $0.88 on January 1st, 2025. Since then, HYPR stock has decreased by 12.6% and is now trading at $0.7690.

Hyperfine, Inc. (NASDAQ:HYPR) issued its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.12) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.12). The business had revenue of $2.14 million for the quarter, compared to the consensus estimate of $2.82 million. Hyperfine had a negative trailing twelve-month return on equity of 74.19% and a negative net margin of 343.42%.
Read the conference call transcript
.

Shares of HYPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hyperfine investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Paycom Software (PAYC), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
5/13/2025
Today
7/14/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:HYPR
CIK
1833769
Fax
N/A
Employees
190
Year Founded
N/A

Price Target and Rating

High Price Target
$1.50
Low Price Target
$0.68
Potential Upside/Downside
+37.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.72 million
Net Margins
-343.42%
Pretax Margin
-343.42%
Return on Equity
-74.19%
Return on Assets
-62.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.07
Quick Ratio
5.48

Sales & Book Value

Annual Sales
$11.73 million
Price / Sales
5.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.67 per share
Price / Book
1.15

Miscellaneous

Outstanding Shares
77,832,000
Free Float
53,720,000
Market Cap
$59.85 million
Optionable
Optionable
Beta
1.01
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:HYPR) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners